Combination use of anti-inflammatory drugs and myorelaxants in the treatment of patients with ankylosing spondylitis in outpatient settings

Objective: to assess different treatment regimens for ankylosing spondylitis (AS). The specific features of using topical and oral nonsteroidal anti-inflammatory drugs (NSAIDs) and myorelaxants in outpatient settings were retrospectively analyzed.Subjects and methods. The investigation enrolled 96 A...

Full description

Saved in:
Bibliographic Details
Main Authors: Inna Zurabievna Gaidukova, O. G. Polyanskaya, A. V. Aparkina, A. P. Rebrov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2015-09-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/634
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849691531321016320
author Inna Zurabievna Gaidukova
O. G. Polyanskaya
A. V. Aparkina
A. P. Rebrov
author_facet Inna Zurabievna Gaidukova
O. G. Polyanskaya
A. V. Aparkina
A. P. Rebrov
author_sort Inna Zurabievna Gaidukova
collection DOAJ
description Objective: to assess different treatment regimens for ankylosing spondylitis (AS). The specific features of using topical and oral nonsteroidal anti-inflammatory drugs (NSAIDs) and myorelaxants in outpatient settings were retrospectively analyzed.Subjects and methods. The investigation enrolled 96 AS patients admitted to the Department of Rheumatology, Saratov Regional Clinical Hospital, in 2010 to 2012, who took nimesulide during the last year (at least three 14-day cycles). The patients' mean age was 42.6±10.9 years; disease duration was 11.9±8.2 years; 83.33% were male. The diagnosis of AS was based on the 1984 modified New York criteria. Physical examination (clinical blood analysis, clinical urinalysis, C-reactive protein, total protein, albumins, urea, creatinine, glucose, bilirubin, serum aspartate aminotransferase and alanine aminotransferase) was made. AS activity was determined using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Axial skeleton mobility and cervical spine rotation were evaluated. Therapy received by the patients at the moment of hospitalization and the attending physicians' recommendations for discharging patients from the hospital were analyzed. Saratov outpatient physicians were interviewed using a questionnaire to specify the aims and procedures of using anti-inflammatory drugs.Results. The outpatient physicians (n=100) were shown to use three-, two-, and one-component therapy in 53.12, 45, and 2% of the AS patients, respectively. Higher lumbar spine mobility and comparably reduced pain were established in the patients receiving threecomponent therapy (a combination of nimesulide 200 mg/day, tizanidine 4–8 mg/day, and topical NSAIDs) than those who had NSAIDs only.
format Article
id doaj-art-bbede4e3625f48bc929b0381a4e7addc
institution DOAJ
issn 1996-7012
2310-158X
language Russian
publishDate 2015-09-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj-art-bbede4e3625f48bc929b0381a4e7addc2025-08-20T03:20:59ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2015-09-0193212510.14412/1996-7012-2015-3-21-251928Combination use of anti-inflammatory drugs and myorelaxants in the treatment of patients with ankylosing spondylitis in outpatient settingsInna Zurabievna Gaidukova0O. G. Polyanskaya1A. V. Aparkina2A. P. Rebrov3V.I. Razumovsky Saratov State Medical University, Ministry of Health of RussiaV.I. Razumovsky Saratov State Medical University, Ministry of Health of RussiaV.I. Razumovsky Saratov State Medical University, Ministry of Health of RussiaV.I. Razumovsky Saratov State Medical University, Ministry of Health of RussiaObjective: to assess different treatment regimens for ankylosing spondylitis (AS). The specific features of using topical and oral nonsteroidal anti-inflammatory drugs (NSAIDs) and myorelaxants in outpatient settings were retrospectively analyzed.Subjects and methods. The investigation enrolled 96 AS patients admitted to the Department of Rheumatology, Saratov Regional Clinical Hospital, in 2010 to 2012, who took nimesulide during the last year (at least three 14-day cycles). The patients' mean age was 42.6±10.9 years; disease duration was 11.9±8.2 years; 83.33% were male. The diagnosis of AS was based on the 1984 modified New York criteria. Physical examination (clinical blood analysis, clinical urinalysis, C-reactive protein, total protein, albumins, urea, creatinine, glucose, bilirubin, serum aspartate aminotransferase and alanine aminotransferase) was made. AS activity was determined using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Axial skeleton mobility and cervical spine rotation were evaluated. Therapy received by the patients at the moment of hospitalization and the attending physicians' recommendations for discharging patients from the hospital were analyzed. Saratov outpatient physicians were interviewed using a questionnaire to specify the aims and procedures of using anti-inflammatory drugs.Results. The outpatient physicians (n=100) were shown to use three-, two-, and one-component therapy in 53.12, 45, and 2% of the AS patients, respectively. Higher lumbar spine mobility and comparably reduced pain were established in the patients receiving threecomponent therapy (a combination of nimesulide 200 mg/day, tizanidine 4–8 mg/day, and topical NSAIDs) than those who had NSAIDs only.https://mrj.ima-press.net/mrj/article/view/634ankylosing spondylitischronic spinal inflammatory painaxial skeleton mobilitytizanidinenimesulide
spellingShingle Inna Zurabievna Gaidukova
O. G. Polyanskaya
A. V. Aparkina
A. P. Rebrov
Combination use of anti-inflammatory drugs and myorelaxants in the treatment of patients with ankylosing spondylitis in outpatient settings
Современная ревматология
ankylosing spondylitis
chronic spinal inflammatory pain
axial skeleton mobility
tizanidine
nimesulide
title Combination use of anti-inflammatory drugs and myorelaxants in the treatment of patients with ankylosing spondylitis in outpatient settings
title_full Combination use of anti-inflammatory drugs and myorelaxants in the treatment of patients with ankylosing spondylitis in outpatient settings
title_fullStr Combination use of anti-inflammatory drugs and myorelaxants in the treatment of patients with ankylosing spondylitis in outpatient settings
title_full_unstemmed Combination use of anti-inflammatory drugs and myorelaxants in the treatment of patients with ankylosing spondylitis in outpatient settings
title_short Combination use of anti-inflammatory drugs and myorelaxants in the treatment of patients with ankylosing spondylitis in outpatient settings
title_sort combination use of anti inflammatory drugs and myorelaxants in the treatment of patients with ankylosing spondylitis in outpatient settings
topic ankylosing spondylitis
chronic spinal inflammatory pain
axial skeleton mobility
tizanidine
nimesulide
url https://mrj.ima-press.net/mrj/article/view/634
work_keys_str_mv AT innazurabievnagaidukova combinationuseofantiinflammatorydrugsandmyorelaxantsinthetreatmentofpatientswithankylosingspondylitisinoutpatientsettings
AT ogpolyanskaya combinationuseofantiinflammatorydrugsandmyorelaxantsinthetreatmentofpatientswithankylosingspondylitisinoutpatientsettings
AT avaparkina combinationuseofantiinflammatorydrugsandmyorelaxantsinthetreatmentofpatientswithankylosingspondylitisinoutpatientsettings
AT aprebrov combinationuseofantiinflammatorydrugsandmyorelaxantsinthetreatmentofpatientswithankylosingspondylitisinoutpatientsettings